2022
|
P/S
|
Computer hardware and recorded software sold as a unit for diagnosing, monitoring, measuring, cal... |
|
P/S
|
Software; software and hardware for diagnosing, monitoring,
measuring, calculating, analysing an... |
2020
|
P/S
|
Software and hardware for diagnosing, monitoring, measuring,
calculating, analysing and displayi... |
2017
|
Invention
|
Process for improving crystallinity.
This invention provides a process for increasing the crysta... |
|
Invention
|
Japanese pollen allergen peptides for preventing or treating allergy. A polypeptide or a pharmace... |
2016
|
Invention
|
Compositions with reduced dimer formation.
The present invention relates to the use of a non-red... |
|
Invention
|
Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy.
The present inv... |
|
Invention
|
Peptide with multiple epitopes.
The present invention relates to peptides comprising multiple MH... |
2015
|
Invention
|
Pharmaceutical compositions.
This invention provides a pharmaceutical composition comprising a e... |
|
Invention
|
Compositions with reduced dimer formation. The present invention relates to the use of a non-redu... |
|
P/S
|
Pharmaceutical and medicinal preparations and substances. Medical apparatus and instruments; inha... |
|
Invention
|
Process for making crystals. A process for preparing crystalline particles of an active principal... |
|
Invention
|
Vaccine peptide combinations against cat allergy.
The present invention relates to compositions ... |
|
P/S
|
Pharmaceutical and veterinary preparations and substances;
pharmaceutical and veterinary prepara... |
|
P/S
|
Pharmaceutical and veterinary preparations and substances; pharmaceutical and veterinary preparat... |
|
Invention
|
Peptides for vaccine against birch allergy.
The present invention relates to compositions compri... |
2014
|
P/S
|
Pharmaceutical and veterinary preparations; vaccines. Surgical, medical and veterinary apparatus ... |
|
P/S
|
Pharmaceutical preparations for testing, diagnosis and treatment of allergies, autoimmune disease... |
|
Invention
|
Peptides for vaccine.
The present invention relates to compositions comprising peptides for prev... |
|
Invention
|
T-cell antigen peptide from allergen for stimulation of il-10 production.
A first or second poly... |
|
Invention
|
Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in ... |
|
Invention
|
Multi-component crystalline particles for inhalation therapy.
Pharmaceutical Preparations Multi-... |
|
Invention
|
Peptide for vaccine.
The present invention relates to compositions comprising peptides for preve... |
2013
|
Invention
|
Peptide with reduced dimer formation.
The present invention relates to peptide which are formula... |
|
Invention
|
Japanese cedar peptide for preventing or treating allergy. A polypeptide which may be used for pr... |
|
Invention
|
Cladosporium peptides. Alternaria genus, have up to 30 amino acids in length and comprise: (I) th... |
|
Invention
|
Alternaria peptides.
Pharmaceutical formulations, which may be used for preventing or treating a... |
|
Invention
|
Cladosporium peptides. Polypeptides which may be used for preventing or treating allergy to mould... |
|
Invention
|
Alternaria peptides. Pharmaceutical formulations,which may be used for preventing or treating all... |
|
Invention
|
Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy. T... |
2012
|
Invention
|
Pharmaceutical compositions. This invention provides a pharmaceutical composition comprising a eu... |
2011
|
Invention
|
Peptides for vaccine against birch allergy. The present invention relates to compositions compris... |
|
Invention
|
Peptides for vaccines against birch allergy. The present invention relates to compositions compri... |
2010
|
Invention
|
Barrier composition. The invention provides a process for increasing the crystallinity of at leas... |
|
Invention
|
T cell epitopes of the cyn d 1 allergen from bermuda grass pollen. The present invention relates ... |
|
Invention
|
Grass peptides for vaccine. The present invention relates to compositions comprising peptides for... |
|
Invention
|
Grass peptides for vaccine. The present invention relates to compositions comprising peptid... |
2009
|
Invention
|
Compositions with reduced dimer formation. The present invention relates to the use of a no... |
|
Invention
|
Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy. The present inve... |
|
Invention
|
T-cell antigen peptide from allergen for stimulation of il-10 production. wherein said disorder i... |
|
Invention
|
Ragweed peptides for vaccine. The present invention relates to compositions for preventing ... |
|
Invention
|
T-cell antigen peptide from allergen for stimulation of il-10 production. A first or second polyp... |
|
Invention
|
Process for improving crystallinity. This invention provides a process for increasing the crystal... |
2008
|
Invention
|
Peptide with reduced dimer formation. The present invention relates to peptides which are formula... |
|
Invention
|
Peptide with multiple epitopes. The present invention relates to peptides comprising multiple MHC... |
|
Invention
|
Peptide for vaccine. The present invention relates to compositions comprising peptides for preven... |
|
Invention
|
Process for making crystals. A process for preparing an emulsion or a dispersion comprising cryst... |
|
Invention
|
Vaccine peptide combinations against cat allergy. The present invention relates to compositions c... |
|
Invention
|
Prognostic assay for determining t cell response to hla antigens and use thereof in field of tiss... |